The pandemic accelerated Mayo Clinic's digital transformation, and it will continue to invest in virtual care and technology for its smart hospital.

Artificial intelligence company DarwinAI and open-source cloud software vendor Red Hat tapped Boston Children's Hospital to help develop and expand their joint COVID-Net neural imaging tool for rapidly screening COVID-19 and assessing disease severity. 

Rochester, Minn.-based Mayo Clinic partnered with an Israel-based company to develop new voice-based tools for patient screening and monitoring.

Eko, a San Francisco-based startup developing artificial intelligence for heart disease screening, telehealth and remote patient monitoring, closed a $65 million Series C funding round, according to a Nov. 9 Wall Street Journal report.

Boston Children's Hospital sold artificial intelligence technology developed at the hospital to building technologies provider Lumenix.

Abridge, an artificial intelligence tool that records patient and clinician conversations and generates a post-visit summary for the patient, launched its new app Oct. 6 after finalizing $15 million in funding. 

Anthem is extending its partnership with artificial intelligence platform doc.ai to help the Indianapolis-based payer grow its digital health offerings, according to a Sept. 29 news release.

New Hyde, N.Y.-based Northwell Health created a new predictive tool that can anticipate a spike in COVID-19 cases at its hospitals by mining user data patterns from the system's website, according to a Sept. 30 news release.

Effective collaboration between payers and providers can be challenging, particularly as more people receive care outside of the hospital and providers shift to reimbursement based on quality of care, rather than volume.

The pandemic shifted strategic focus and investments for Rochester, Minn.-based Mayo Clinic as the system sought to treat patients safely and using resources responsibly during the early days.